NNC 01-0687

From WikiMD's Medical Encyclopedia

Chemical compound



Chemical structure of NNC 01-0687

NNC 01-0687 is a chemical compound that acts as a selective antagonist of the vasopressin receptor V1A. It is primarily used in scientific research to study the physiological and pathological roles of the V1A receptor.

Chemical Properties[edit]

NNC 01-0687 is a small molecule with a specific chemical structure that allows it to bind selectively to the V1A receptor. The compound's structure is depicted in the adjacent image, which shows its molecular configuration.

Mechanism of Action[edit]

NNC 01-0687 functions by inhibiting the action of arginine vasopressin (AVP) at the V1A receptor. This receptor is a subtype of the vasopressin receptor family, which also includes V1B and V2 receptors. The V1A receptor is primarily involved in vasoconstriction and the regulation of blood pressure.

Pharmacological Effects[edit]

By blocking the V1A receptor, NNC 01-0687 can reduce vasopressin-induced vasoconstriction, leading to a decrease in blood pressure. This makes it a valuable tool in research settings for studying cardiovascular functions and disorders related to vasopressin signaling.

Research Applications[edit]

NNC 01-0687 is used extensively in preclinical studies to explore the role of the V1A receptor in various physiological processes. It has been instrumental in advancing our understanding of the cardiovascular system, as well as in the development of potential therapeutic agents targeting vasopressin receptors.

Potential Therapeutic Uses[edit]

While NNC 01-0687 itself is not used clinically, its ability to modulate the V1A receptor has implications for the treatment of conditions such as hypertension and heart failure. Research continues to explore the therapeutic potential of V1A receptor antagonists in these areas.

Related Pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.